(Q33202606)

English

The impact of hormone receptor status on the clinical efficacy of the new-generation aromatase inhibitors: a review of data from first-line metastatic disease trials in postmenopausal women

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 July 2017

0 references

The impact of hormone receptor status on the clinical efficacy of the new-generation aromatase inhibitors: a review of data from first-line metastatic disease trials in postmenopausal women (English)

1 reference

Europe PubMed Central

23 July 2017

2

object named as

Ignace Vergote

1 reference

Europe PubMed Central

23 July 2017

Richard Sainsbury

3

object named as

Richard Sainsbury

1 reference

Europe PubMed Central

23 July 2017

1

object named as

Aman U Buzdar

1 reference

Europe PubMed Central

23 July 2017

publication date

1 May 2004

1 reference

Europe PubMed Central

23 July 2017

The Breast Journal

1 reference

Europe PubMed Central

23 July 2017

10

1 reference

Europe PubMed Central

23 July 2017

211-217

1 reference

Europe PubMed Central

23 July 2017

3

1 reference

Europe PubMed Central

23 July 2017

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2004.21320.X

21 January 2018

Anastrozole (Arimidex) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2004.21320.X

21 January 2018

Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2004.21320.X

21 January 2018

Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2004.21320.X

21 January 2018

Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2004.21320.X

21 January 2018

Aromatase inhibitors in advanced breast cancer: mechanism of action and clinical implications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1075-122X.2004.21320.X

21 January 2018

Identifiers

10.1111/J.1075-122X.2004.21320.X

1 reference

Europe PubMed Central

23 July 2017

1 reference

Europe PubMed Central

23 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33202606&oldid=2121329220"